{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:45:08Z","timestamp":1787010308994,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:sup>68<\/jats:sup>\n                    Ga-labeled prostate-specific membrane antigen (PSMA)-11 PET\/CT has evolved as the noninvasive imaging modality of choice in prostatic adenocarcinoma to detect overexpression of PSMA on prostate cancer cells. Metastasis to the thyroid gland is rarely observed in clinical practice of prostatic adenocarcinoma. Herein, we report the first and rare case of metastatic castration-resistant prostatic adenocarcinoma with thyroid metastasis. The patient demonstrated intensely PSMA-expressing primary prostatic lesion, metastatic lymph nodes, and skeletal lesions, and also mild uptake in thyroid nodule, which on further investigations was established as thyroid metastasis from prostate adenocarcinoma.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000003954","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T02:02:09Z","timestamp":1635127329000},"page":"e300-e301","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Thyroid Incidentaloma on 68Ga-PSMA-11 PET\/CT Leading to Detection of Thyroid Metastasis in Metastatic Prostate Carcinoma"],"prefix":"10.1097","volume":"47","author":[{"given":"Rahul V.","family":"Parghane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,22]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"20190380","DOI":"10.1259\/bjr.20190380","article-title":"Therapeutic efficacy, prognostic variables and clinical outcome of 177Lu-PSMA-617 PRLT in progressive mCRPC following multiple lines of treatment: prognostic implications of high FDG uptake on dual tracer PET-CT vis-\u00e0-vis Gleason score in such cohort","volume":"92","year":"2019","journal-title":"Br J Radiol"},{"key":"bib3-20250621","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","year":"1997","journal-title":"Clin Cancer Res"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO;2-S","article-title":"Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases","volume":"82","year":"1998","journal-title":"Cancer"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12253-008-9104-2","article-title":"Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis","volume":"15","year":"2009","journal-title":"Pathol Oncol Res"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2967\/jnmt.118.215582","article-title":"Small cell transformation of metastatic prostate adenocarcinoma diagnosed by dual-tracer PET\/CT (68Ga-PSMA and 18F-FDG): potential clinical utility in therapeutic decision making and treatment monitoring","volume":"47","year":"2019","journal-title":"J Nucl Med Technol"},{"key":"bib7-20250621","first-page":"551","article-title":"Carcinomas metastatic to follicular adenomas of the thyroid gland. Report of two cases","volume":"118","year":"1994","journal-title":"Arch Pathol Lab Med"},{"key":"bib8-20250621","first-page":"132","article-title":"Metastatic prostate cancer on the thyroid cartilage: unusual symptoms of prostatic adenocarcinoma. Case report","volume":"64","year":"2011","journal-title":"Arch Esp Urol"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-7819-5-2","article-title":"Metastatic prostate cancer masquerading clinically and radiologically as a primary caecal carcinoma","volume":"5","year":"2007","journal-title":"World J Surg Oncol"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12022-013-9232-4","article-title":"Isolated multiple bilateral thyroid metastases from prostatic adenocarcinoma: case report and literature review","volume":"24","year":"2013","journal-title":"Endocr Pathol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T16:06:33Z","timestamp":1750521993000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003954","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,22]]}}}